These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18712621)

  • 1. Optimization of iontophoretic parameters for the transdermal delivery of methotrexate.
    Vemulapalli V; Banga AK; Friden PM
    Drug Deliv; 2008 Sep; 15(7):437-42. PubMed ID: 18712621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive and iontophoretic transdermal penetration of methotrexate.
    Alvarez-Figueroa MJ; Delgado-Charro MB; Blanco-Méndez J
    Int J Pharm; 2001 Jan; 212(1):101-7. PubMed ID: 11165825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate.
    Vemulapalli V; Yang Y; Friden PM; Banga AK
    J Pharm Pharmacol; 2008 Jan; 60(1):27-33. PubMed ID: 18088502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iontophoretic transdermal delivery of sumatriptan: effect of current density and ionic strength.
    Femenía-Font A; Balaguer-Fernández C; Merino V; López-Castellano A
    J Pharm Sci; 2005 Oct; 94(10):2183-6. PubMed ID: 16136550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.
    Eljarrat-Binstock E; Domb AJ; Orucov F; Frucht-Pery J; Pe'er J
    Curr Eye Res; 2007; 32(7-8):639-46. PubMed ID: 17852187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo iontophoretic transdermal delivery of an anti-parkinsonian agent.
    Vemulapalli V; Yang Y; Siddoju S; Conjeevaram R; Teunissen H; Myers T; Banga AK
    Int J Pharm; 2011 Nov; 420(1):20-5. PubMed ID: 21856395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response surface methodology to investigate the iontophoretic delivery of tacrine hydrochloride.
    Upasani RS; Banga AK
    Pharm Res; 2004 Dec; 21(12):2293-9. PubMed ID: 15648261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
    Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
    Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
    Kumar MG; Lin S
    Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
    Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
    Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
    Patel N; Jain S; Lin S
    Int J Pharm; 2016 Nov; 513(1-2):393-403. PubMed ID: 27633278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal iontophoretic delivery of triptorelin in vitro.
    Schuetz YB; Naik A; Guy RH; Vuaridel E; Kalia YN
    J Pharm Sci; 2005 Oct; 94(10):2175-82. PubMed ID: 16136544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin.
    Al-Khalili M; Meidan VM; Michniak BB
    AAPS PharmSci; 2003; 5(2):E14. PubMed ID: 12866941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iontophoretic transdermal delivery of haloperidol.
    Alvarez-Figueroa MJ; Araya-Silva I; Díaz-Tobar C
    Pharm Dev Technol; 2006; 11(3):371-5. PubMed ID: 16895847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of in vitro iontophoresis facilitated transdermal delivery of glycine.
    Dasgupta R; Banthia AK; Tibarewala DN
    Curr Drug Deliv; 2009 Apr; 6(2):145-50. PubMed ID: 19450220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To enhance the efficiency of nefopam transdermal iontophoresis by using a novel method based on ion-exchange fiber.
    Xin C; Lihong W; Fei H; Yan W; Qifang W; Yang Y; Yue Y; San-ming L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):9-16. PubMed ID: 23317337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers.
    Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L
    Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of acyclovir cream and gel formulations for transdermal iontophoretic delivery.
    Siddoju S; Sachdeva V; Friden PM; Banga AK
    Ther Deliv; 2012 Mar; 3(3):327-38. PubMed ID: 22833993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.